Understanding Lobular Breast Cancer: Updates on Research, Treatment, Resources, and Support

Join Us for an Informative Online Session 

If you have been diagnosed with invasive lobular carcinoma (ILC) breast cancer, this session is designed for you. Learn how ILC differs from other breast cancer types, what that means for detection and treatment, and how current research is shaping care today and in the future. 

This session is open to patients, care partners, staff, and anyone who wants to better understand invasive lobular carcinoma breast cancer. You will hear from clinical experts as well as people affected by ILC, offering both medical updates and lived experience. 

Important Disclaimer

This session is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Please talk with your oncology care team about your individual situation.

What Is Invasive Lobular Carcinoma (ILC)? 

Invasive lobular carcinoma (ILC) is a type of breast cancer that accounts for about 10–15% of breast cancer diagnoses in the United States. It begins in the lobules, the milk‑producing glands of the breast, and has the ability to spread into nearby breast tissue and beyond. 

ILC cells tend to spread in thin lines rather than forming a firm lump. This pattern can make ILC harder to detect on routine imaging and may lead to diagnosis at a later stage than some other breast cancers. Symptoms can be subtle and may include breast fullness, thickening, or changes in breast shape rather than a distinct mass. ILC is also more likely to affect more than one area of the breast or, in some cases, both breasts. 

Because much breast cancer research and education has focused on ductal cancer (IDC), some people with lobular breast cancer may feel that available information does not fully reflect their experience. As research grows, care, education, and support for ILC continue to improve. 

Why This Session Matters 

ILC can go into remission, especially when found and treated early. Some people reach complete remission, while others may manage ILC over time with ongoing treatment. Therapies such as endocrine treatment or other medications may help control the disease, reduce the risk of progression, and support quality of life. 

Because ILC may behave differently and may return later, understanding long-term follow-up care is important. Staying informed about research and new treatment options can also help you make informed decisions about your care plan.

What You’ll Learn

• How ILC differs from other breast cancers and why it matters
• Symptoms, detection challenges, and imaging considerations
• Updates on research and treatment, including long‑term care
• Insights from people living with ILC
• Questions to ask your care team
• Support, education, and advocacy resources

We’re glad you’re here. Thank you for joining us—this is a supportive, welcoming space to learn, connect, and ask questions.

Session Guidelines, Privacy, and Registration

Before You Join

• Joining is your choice. You’re welcome to turn your camera on or off, or step away at any time.
• This session is for learning and support. It does not replace medical advice. Please talk with your oncology care team about what is best for you.
• This session will not be recorded. Registration is free. After you sign up, you’ll receive a Microsoft Teams link and instructions by email.

During the Session

• Please join from a private, quiet space where others cannot hear the discussion or see your screen.
• Share only what feels comfortable for you.
• You’re welcome to ask questions in the chat or during Q&A, as time allows.

Privacy and Respect

• Everyone’s privacy matters. Please keep personal stories, names, images, and medical information shared here within this group.
• Recording or screenshots are not allowed at any time during the session.
• Atrium Health uses third‑party platforms such as Microsoft Teams or Zoom. By joining, you understand and accept their features and security limits, and that complete confidentiality cannot be guaranteed. Atrium Health is not responsible for privacy breaches. While we make every effort to respect your privacy, facilitators may step in if there are safety or privacy concerns, which could include contacting appropriate authorities.

Need Help or Have Questions?

Contact the Cancer Resource Center at (980) 442-1006 or email LCISupportiveOncology@advocatehealth.org for help with registration, a program calendar, or breast cancer resources.

Thank You

This session is offered in partnership with the Sandra Levine Young Women’s Breast Cancer Program (YWBP) and the Department of Supportive Oncology at Atrium Health Levine Cancer, Charlotte, NC, part of Advocate Health.